Fate Therapeutics Inc (FATE)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current FATE market cap is 390.03M. The company's latest EPS is USD -1.4132 and P/E is -2.44.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 58.98M | 933k | 1.94M | 1.68M | 1.93M |
| Operating Income | -28.59M | -62.57M | -51.28M | -48.08M | -51.07M |
| Net Income | -18.88M | -52.76M | -45.17M | -44.12M | -48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.68M | 31.43M | 55.85M | 96.3M | 63.53M |
| Operating Income | -100.73M | -128.09M | -216.99M | -308.39M | -190.51M |
| Net Income | -98.15M | -173.39M | -212.15M | -281.72M | -160.93M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 630.34M | 584.76M | 543.79M | 506.22M | 569.89M |
| Total Liabilities | 152.86M | 147M | 141.01M | 137.8M | 143.78M |
| Total Equity | 477.47M | 437.76M | 402.78M | 368.42M | 426.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 302.27M | 622.46M | 921.46M | 705.56M | 506.22M |
| Total Liabilities | 57.52M | 238.01M | 242.62M | 221.62M | 137.8M |
| Total Equity | 244.76M | 384.45M | 678.84M | 483.94M | 368.42M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28.86M | -57.35M | -95.63M | -132.26M | -33.35M |
| Investing | 9.34M | 42.51M | 67.31M | 112.67M | 17.31M |
| Financing | 207k | 265k | 265k | 85k | 95.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -83.18M | -39.23M | -162.87M | -248.21M | -132.26M |
| Investing | -157.45M | -161.08M | -324.02M | 166.75M | 112.67M |
| Financing | 149.93M | 282.84M | 453.13M | 9.21M | 85k |
| Market Cap | 390.03M |
| Price to Earnings Ratio | -2.44 |
| Price to Sales Ratio | 6.18 |
| Price to Cash Ratio | 9.38 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 113.88M |
| Average Volume (1 week) | 1.24M |
| Average Volume (1 Month) | 1.04M |
| 52 Week Change | 63.88% |
| 52 Week High | 8.83 |
| 52 Week Low | 1.63 |
| Spread (Intraday) | 0.01 (0.29%) |
| Company Name | Fate Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.fatetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
